Vertex Q3 Revenue Reaches USD 3,440 Million
Vertex Pharmaceuticals reported Q3 revenue of USD 3,440 million, compared with the IBES estimate of USD 3,417 million.
Vertex Pharmaceuticals reported Q3 revenue of USD 3,440 million, compared with the IBES estimate of USD 3,417 million.